Pharnext France (PNEXF) Stock Price, News & Analysis

Name: Pharnext France (PNEXF) Financial Data & Stock Overview
Creator: Stock Titan
License: https://www.stocktitan.net/terms-of-use

PNEXF OTC

Company Description

Pharnext France (OTC: PNEXF) is classified in the research and development in biotechnology industry within the Professional, Scientific, and Technical Services sector.

This page collects what Stock Titan holds for PNEXF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

Market Cap

78.0

Shares outstanding

Latest News

View All

April 27, 2021

0.00%

Pharnext Reports Financial Results for Year-End 2020

earnings

March 31, 2021

0.00%

Pharnext Announces First Patient Enrolled in the PREMIER Trial, its Pivotal Phase III Clinical Development Program of PXT3003 in Charcot-Marie-Tooth Disease Type 1A ('CMT1A')

clinical trial

February 4, 2021

0.00%

Pharnext Announces Financing of €11 Million Through a Capital Raise Subscribed by Existing Shareholders and a Convertible Bonds Issued to European Investors

Pharnext France has 3 recent news articles. Key topics include earnings, clinical trial. View all PNEXF news →

SEC Filings

View All

No SEC filings available for PNEXF.

Financial Highlights

—

Revenue (latest FY)

—

Net Income (latest FY)

—

Diluted EPS (latest FY)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

PNEXF Company Profile & Sector Positioning

Pharnext France (PNEXF) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the OTC.